ProQR Therapeutics (PRQR) Amortization (2021 - 2025)
Historic Amortization for ProQR Therapeutics (PRQR) over the last 5 years, with Q3 2025 value amounting to $1169.1.
- ProQR Therapeutics' Amortization rose 10001.25% to $1169.1 in Q3 2025 from the same period last year, while for Sep 2025 it was $1169.1, marking a year-over-year increase of 10000.44%. This contributed to the annual value of $1082.3 for FY2024, which is 5.74% up from last year.
- According to the latest figures from Q3 2025, ProQR Therapeutics' Amortization is $1169.1, which was up 10001.25% from $1132.0 recorded in Q2 2025.
- ProQR Therapeutics' Amortization's 5-year high stood at $1206.2 during Q1 2021, with a 5-year trough of -$19.1 million in Q2 2021.
- In the last 5 years, ProQR Therapeutics' Amortization had a median value of $1020.2 in 2022 and averaged -$4.8 million.
- Per our database at Business Quant, ProQR Therapeutics' Amortization plummeted by 131361079.74% in 2022 and then surged by 10003.9% in 2025.
- ProQR Therapeutics' Amortization (Quarter) stood at $1144.0 in 2021, then fell by 10.82% to $1020.2 in 2022, then grew by 5.46% to $1075.9 in 2023, then dropped by 0.68% to $1068.6 in 2024, then rose by 9.4% to $1169.1 in 2025.
- Its Amortization stands at $1169.1 for Q3 2025, versus $1132.0 for Q2 2025 and -$11.0 million for Q1 2025.